IRA Draft Guidance Leaves 340B Details Unclear

The latest CMS guidance on implementing the Inflation Reduction Act's Medicare price caps left unresolved key 340B pricing details.
Recently released draft guidance for implementing Medicare price caps would allow voluntary provider use of 340B codes on claims, while [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

U.S. Drug Spending Increased 14 Percent in 2023; Clinic, Hospital Trends Diverge

Eric Tichy led research with seven of his colleagues that examined U.S. drug spending trends in 2023.
Drug spending increased by 13.6% in 2023 to $722.5 billion, according to recent research. It found divergent trends for clinic [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

NC Treasurer Report Suggests 340B Hospitals Overcharged State Health Plan, Hospitals Pan the Findings

A report from N.C. Treasurer Dale Folwell found some hospitals are using 340B “to enrich themselves rather than to serve vulnerable communities.”
North Carolina hospitals that participate in the 340B program routinely overcharged cancer patients, taxpayers and state employees for oncology drugs, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospital Groups Ask MedPAC to Oppose Part B Rate Cut

Jonathan Jaffery, chief health care officer for AAMC, said reduced Medicare reimbursement to 340B hospitals would “devastate an already fragile health care safety net.”
Groups representing hospitals that rely on the 340B program recently urged congressional advisers against recommending reduced Medicare reimbursement to 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Webinar – It’s a Risky Business: Risk Mitigation and 340B Program Compliance

SPONSORED CONTENT

Attention 340B Covered Entities:  For most covered entities, the 340B program is essential to their organization’s bottom line – so protecting it becomes necessary. 340B program risks are numerous and often not fully recognized. Duplicate discounts, diversion, and poor documentation are common

Read More »

Pfizer Exempts Arkansas Hospitals from All Contract Pharmacy Restrictions

Pfizer is one of more than 20 drugmakers to fully or partially exempt Arkansas providers from its 340B contract pharmacy restrictions.
Pharmaceutical giant Pfizer announced it exempted Arkansas hospitals from its 340B contract pharmacy restrictions beginning this week. Effective May 6, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Delaware Lawmakers Introduce 340B Contract Pharmacy Access, PBM Payment Bill

Delaware’s legislature passed a slimmed-down version of a 340B anti-discrimination bill in the eleventh hour of its legislative session Sunday.
Influential Delaware Democratic lawmakers last week introduced legislation to bar drugmaker 340B contract pharmacy restrictions and prohibit certain 340B-specific pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Study Finds Newer 340B Public Hospitals More Likely to Increase Unprofitable Service Lines Than Newer Non-Profit Hospitals

Government-owned 340B hospitals recently enrolled in 340B were more likely to increase unprofitable services than new 340B nonprofit hospitals, a recent study found.
While newly enrolled 340B hospital entrants served higher numbers of Medicaid and rural patients than non-340B hospitals, government-owned 340B hospitals [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Eight More Provider Audits Closed with Corrective Action Plans in Latest HRSA Audit Findings

HRSA's latest update to its ongoing fiscal year 2023 program integrity audits included corrective action plans for eight 340B providers.
Federal auditors closed audits with corrective action plans (CAPs) for eight more 340B providers, which brought the fiscal year 2023 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Novo to Extend Contract Pharmacy Restrictions to Grantees But Allow Them to Keep Access Under Conditions; Company Also Modifies Hospital Policy

Pharmaceutical manufacturer Novo Nordisk recently announced it will extend its 340B contract pharmacy restrictions to federal grantees.
Drugmaker Novo Nordisk this week announced that its contract pharmacy restrictions will soon apply to all grantee covered entities—not just [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live